Leptin-stimulated tumor growth is not limited to breast cancer, but is to melanoma [14] and prostate cancer [15] and several other obesity-linked cancer types recently reviewed by Modzelewska and colleagues [16]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.